218 related articles for article (PubMed ID: 22299025)
1. Class II MHC self-antigen presentation in human B and T lymphocytes.
Costantino CM; Spooner E; Ploegh HL; Hafler DA
PLoS One; 2012; 7(1):e29805. PubMed ID: 22299025
[TBL] [Abstract][Full Text] [Related]
2. Invariant chains with the class II binding site replaced by a sequence from influenza virus matrix protein constrain low-affinity sequences to MHC II presentation.
Carstens C; Newman DK; Bohlen H; König A; Koch N
Int Immunol; 2000 Nov; 12(11):1561-8. PubMed ID: 11058576
[TBL] [Abstract][Full Text] [Related]
3. LAMP-2-deficient human B cells exhibit altered MHC class II presentation of exogenous antigens.
Crotzer VL; Glosson N; Zhou D; Nishino I; Blum JS
Immunology; 2010 Nov; 131(3):318-30. PubMed ID: 20518820
[TBL] [Abstract][Full Text] [Related]
4. Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients.
Chornoguz O; Gapeev A; O'Neill MC; Ostrand-Rosenberg S
Mol Cell Proteomics; 2012 Nov; 11(11):1457-67. PubMed ID: 22942358
[TBL] [Abstract][Full Text] [Related]
5. HLA-DR4 molecules in neuroendocrine epithelial cells associate to a heterogeneous repertoire of cytoplasmic and surface self peptides.
Muntasell A; Carrascal M; Serradell L; Veelen Pv Pv; Verreck F; Koning F; Raposo G; Abián J; Jaraquemada D
J Immunol; 2002 Nov; 169(9):5052-60. PubMed ID: 12391221
[TBL] [Abstract][Full Text] [Related]
6. Distinguishing Signal From Noise in Immunopeptidome Studies of Limiting-Abundance Biological Samples: Peptides Presented by I-A
Nanaware PP; Jurewicz MM; Clement CC; Lu L; Santambrogio L; Stern LJ
Front Immunol; 2021; 12():658601. PubMed ID: 33995376
[TBL] [Abstract][Full Text] [Related]
7. HLA-DR-presented peptide repertoires derived from human monocyte-derived dendritic cells pulsed with blood coagulation factor VIII.
van Haren SD; Herczenik E; ten Brinke A; Mertens K; Voorberg J; Meijer AB
Mol Cell Proteomics; 2011 Jun; 10(6):M110.002246. PubMed ID: 21467215
[TBL] [Abstract][Full Text] [Related]
8. Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides.
Wang M; Tang ST; Stryhn A; Justesen S; Larsen MV; Dziegiel MH; Lewinsohn DM; Buus S; Lund O; Claesson MH
Immunology; 2011 Apr; 132(4):482-91. PubMed ID: 21294723
[TBL] [Abstract][Full Text] [Related]
9. In vivo MHC class II presentation of cytosolic proteins revealed by rapid automated tandem mass spectrometry and functional analyses.
Dongre AR; Kovats S; deRoos P; McCormack AL; Nakagawa T; Paharkova-Vatchkova V; Eng J; Caldwell H; Yates JR; Rudensky AY
Eur J Immunol; 2001 May; 31(5):1485-94. PubMed ID: 11465105
[TBL] [Abstract][Full Text] [Related]
10. Functional HLA-DM on the surface of B cells and immature dendritic cells.
Arndt SO; Vogt AB; Markovic-Plese S; Martin R; Moldenhauer G; Wölpl A; Sun Y; Schadendorf D; Hämmerling GJ; Kropshofer H
EMBO J; 2000 Mar; 19(6):1241-51. PubMed ID: 10716924
[TBL] [Abstract][Full Text] [Related]
11. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes.
Kropshofer H; Spindeldreher S; Röhn TA; Platania N; Grygar C; Daniel N; Wölpl A; Langen H; Horejsi V; Vogt AB
Nat Immunol; 2002 Jan; 3(1):61-8. PubMed ID: 11743588
[TBL] [Abstract][Full Text] [Related]
12. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
[TBL] [Abstract][Full Text] [Related]
13. Cathepsin S regulates class II MHC processing in human CD4+ HLA-DR+ T cells.
Costantino CM; Ploegh HL; Hafler DA
J Immunol; 2009 Jul; 183(2):945-52. PubMed ID: 19553543
[TBL] [Abstract][Full Text] [Related]
14. IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4(+) T cells.
Ohno Y; Kitamura H; Takahashi N; Ohtake J; Kaneumi S; Sumida K; Homma S; Kawamura H; Minagawa N; Shibasaki S; Taketomi A
Cancer Immunol Immunother; 2016 Feb; 65(2):193-204. PubMed ID: 26759006
[TBL] [Abstract][Full Text] [Related]
15. Immune responses to self peptides naturally presented by murine class II major histocompatibility complex molecules.
Rider BJ; Fraga E; Yu Q; Singh B
Mol Immunol; 1996; 33(7-8):625-33. PubMed ID: 8760274
[TBL] [Abstract][Full Text] [Related]
16. Human monoclonal antibody with T-cell-like specificity recognizes MHC class I self-peptide presented by HLA-DR1 on activated cells.
Wölpl A; Halder T; Kalbacher H; Neumeyer H; Siemoneit K; Goldmann SF; Eiermann TH
Tissue Antigens; 1998 Mar; 51(3):258-69. PubMed ID: 9550326
[TBL] [Abstract][Full Text] [Related]
17. Impaired antigen presentation by murine I-Ad class II MHC molecules expressed in normal and HLA-DM-defective human B cell lines.
Weenink S; Averdunk H; Boston T; Boswarva V; Guery JC; Adorini L; Mellins E; McCluskey J; Gautam AM
Int Immunol; 1997 Jun; 9(6):889-96. PubMed ID: 9199972
[TBL] [Abstract][Full Text] [Related]
18. Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands.
Paul S; Karosiene E; Dhanda SK; Jurtz V; Edwards L; Nielsen M; Sette A; Peters B
Front Immunol; 2018; 9():1795. PubMed ID: 30127785
[TBL] [Abstract][Full Text] [Related]
19. Toward a definition of self: proteomic evaluation of the class I peptide repertoire.
Hickman HD; Luis AD; Buchli R; Few SR; Sathiamurthy M; VanGundy RS; Giberson CF; Hildebrand WH
J Immunol; 2004 Mar; 172(5):2944-52. PubMed ID: 14978097
[TBL] [Abstract][Full Text] [Related]
20. Predominant HLA-class II bound self-peptides of a hematopoietic progenitor cell line are derived from intracellular proteins.
Harris PE; Maffei A; Colovai AI; Kinne J; Tugulea S; Suciu-Foca N
Blood; 1996 Jun; 87(12):5104-12. PubMed ID: 8652823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
